Disrupt Therapeutics
PrivateLast Round
Grant
Dec 19, 2025
Total Funding Raised
$538,000
Company Overview
Disrupt Therapeutics is a biotechnology company that is developing DRT-101, a peptide-based drug for the treatment of cannabis use disorder (CUD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Disrupt Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Disrupt Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 19, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| VC Round | Jan 1, 2024 | ||||
| Accelerator | Nov 1, 2023 | ||||
| Grant | Sep 28, 2023 | ||||
Seed | Jan 30, 2023 |
Disrupt Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arquimedes Accelerator | Accelerator |
| Agencia Estatal de Investigación | Grant |
| Inveready | VC Round |
| Pompeu Fabra University | Seed |
| University of Barcelona | Seed |
| Center for Technological Development and Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2025
$380K grant received from Center for Technological Development and Innovation.
- Oct 15, 2024
$79K grant received from Agencia Estatal de Investigación
Disrupt Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Disrupt Therapeutics's valuation, stock price, and market status.
